Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 17320513646 |
E-mail: | mike@molcoo.com |
QQ: | 3001071511 |
Skype: | Chat Now! |
Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
Product Name | MF | CAS | Details |
---|
Bilastine Impurity | C27H35N3O3 | 2767508-98-3 | Details |
(Z)-Ozagrel | C13H12N2O2 | 143945-86-2 | Details |
Ponatinib Impurity | C8H4Br2F3NO2 | 122947-77-7 | Details |
Levetiracetam Impurity | C8H13ClN2O2 | 2245069-23-0 | Details |
Argatroban Impurity | C10H9NO3S | 153886-69-2 | Details |
Argatroban Impurity | C11H21N5O6 | 50913-12-7 | Details |
Fludarabine Impurity | C5H4FN5 | 700-49-2 | Details |
Benzaldehyde | C7H6O | 100-52-7 | Details |
Clopidogrel ImpurityCl | C15H14ClNO2S.ClH | 144750-42-5 | Details |
Tretinoin Impurity | C20H28O2 | 4759-48-2 | Details |
Argatroban Impurity | C9H17NO2 | 79199-62-5 | Details |
Sitagliptin Impurity | C16H15F6N5O | 823817-55-6 | Details |
Tenofovir Impurity (Mixture of Diastereomers) | C21H34N5O9P | 1246812-23-6 | Details |
Tenofovir Impurity (Mixture of Diastereomers) | C19H30N5O10P | 1280130-08-6 | Details |
Mono-POC Methyl Tenofovir (Mixture of Diastereomers) | C15H24N5O7P | 1246812-16-7 | Details |
Tenofovir Impurity | C5H9ClO3 | 35273-90-6 | Details |
Tenofovir Impurity | C3H5ClO3 | 40510-81-4 | Details |
Tretinoin Impurity | C20H28O2 | 5352-74-9 | Details |
N1-Trityl Olmesartan Medoxomil | C48H44N6O6 | 144690-92-6 | Details |
Fenofibrate Impurity | C17H15ClO4 | 42017-89-0 | Details |
Baloxavir Impurity | C15H12F2O2S | 2396727-68-5 | Details |
Argatroban Impurity | C10H8ClNO2S | 74863-82-4 | Details |
(R)-Fluorenylethylchloroformate | C16H13ClO2 | 1428936-75-7 | Details |
Tretinoin Impurity | C20H28O2 | 3555-80-4 | Details |
Tretinoin Impurity | C20H28O2 | 5300-03-8 | Details |
Apalutamide Impurity | C13H15FN2O3 | 2227589-22-0 | Details |
Etoposide Impurity | C29H32O13 | 100007-53-2 | Details |
Argatroban Impurity(Hydrochloride) | C15H29ClN6O5 | 74874-08-1 | Details |
Lenalidomide Impurity | C5H8N2O2 | 2353-44-8 | Details |
Tafluprost Impurity | C25H34F2O5 | 2587078-47-3 | Details |
Argatroban Impurity | C9H17NO2 | 78306-52-2 | Details |
Formoterol Impurity (Mixture of Diastereomers) | C20H26N2O4 | 1795133-96-8 | Details |
Thioctic Acid Impurity | C8H16O2S2 | 462-20-4 | Details |
D-Norepinephrine Bitartrate | C12H17NO9 | 636-88-4 | Details |
(S,R)-Formoterol | C19H24N2O4 | 67346-50-3 | Details |
Tenofovir Impurity | C17H23N10O4P | 1878175-77-9 | Details |
Tenofovir Impurity | C18H28N5O10P | 1422284-16-9 | Details |
Tenofovir Impurity | C20H32N5O11P | 1244022-53-4 | Details |
Tenofovir Impurity | C5H9ClO3 | 35180-01-9 | Details |
Thioctic Acid | C8H14O2S2 | 62-46-4 | Details |
Thioctic Acid(Sodium salt) | C8H13NaO2S2 | 2319-84-8 | Details |
Thioctic Acid Impurity | C8H14O2S3 | 1204245-29-3 | Details |
8-chloro-6-oxooctanoic acid | C8H13ClO3 | 56535-97-8 | Details |
Cefpodoxime proxetil Impurity | C15H17N5O6S2 | 80210-62-4 | Details |
S-Tenofovir Disoproxil Fumarate | C20H22N5O16P | 1432630-26-6 | Details |
Tenofovir Impurity | C14H23O6PS | 34956-22-4 | Details |
Tenofovir Impurity | C8H11O6PS | 161760-09-4 | Details |
Tenofovir Impurity | C10H15O6PS | 161760-03-8 | Details |
Tenofovir Impurity | C4H11O3P | 762-04-9 | Details |
(R,S)-Formoterol | C19H24N2O4 | 67346-51-4 | Details |
Formoterol Fumarate Dihydrate | C42H52N4O12 | 43229-80-7 | Details |
Formoterol Impurity (Mixture of Diastereomers) | C20H26N2O4 | 1616967-26-0 | Details |
Tenofovir Impurity | C9H16N5O5P | 206184-49-8 | Details |
Tenofovir Impurity | C8H11N5O | 1244022-52-3 | Details |
Tenofovir Impurity | C7H9N5O | 707-99-3 | Details |
Tenofovir Impurity | C4H6O3 | 16606-55-6 | Details |
Tenofovir Impurity | C11H17N5O2 | 1878175-82-6 | Details |
Tenofovir Impurity | C8H11N5O | 36817-69-3 | Details |
Tenofovir Impurity | C8H11N5O | 14047-27-9 | Details |
S-Tenofovir | C9H14N5O4P | 147127-19-3 | Details |
Atorvastatin Impurity | C33H35FN2O5 | 501121-34-2 | Details |
Atorvastatin Impurity | C66H66CaF4N4O10 | 693794-20-6 | Details |
Atorvastatin Dehydro Lactone | C33H31FN2O3 | 442851-50-5 | Details |
N'-Nitro-L-arginine | C6H13N5O4 | 2149-70-4 | Details |
Dopamine HCl | C8H12ClNO2 | 62-31-7 | Details |
Omacycline Impurity | C50H42N6O13 | 1075171-51-5 | Details |
Bendamustine HCl | C16H22Cl3N3O2 | 3543-75-7 | Details |
Bendamustine Dihydroxy Impurity | C16H23N3O4 | 109882-30-6 | Details |
Ilaprazole Impurity | C7H8ClNO | 59886-90-7 | Details |
Lacosamide Impurity | C7H10ClN | 3287-99-8 | Details |
BETA-D-GLUCOSE PENTAACETATE | C16H22O11 | 83-87-4 | Details |
Bendamustine Impurity | C32H41Cl3N6O4 | 1228551-91-4 | Details |
Bendamustine Impurity | C16H22ClN3O3 | 109882-27-1 | Details |
Loratadine Pyridine N-Oxide | C22H23ClN2O3 | 165739-62-8 | Details |
Galantamine N-Oxide | C17H21NO4 | 199014-26-1 | Details |
Mupirocin Impurity | C26H44O8 | 71980-98-8 | Details |
Bupivacaine N-Oxide(Hydrochloride) | C18H29ClN2O2 | 1796927-05-3 | Details |
Tenofovir Impurity | C9H14N5O4P | 1878175-75-7 | Details |
(S)-Azelastine N-Oxide | C22H24ClN3O2 | 1346617-06-8 | Details |
(R)-Azelastine N-Oxide | C22H24ClN3O2 | 1346617-18-2 | Details |
N-Nitroso-di-iso-propylamine | C6H14N2O | 601-77-4 | Details |
(1S,4β)-1α,7,7-Trimethylbicyclo[2.2.1]heptane-2β-ol | C10H18O | 16725-71-6 | Details |
Amoxicillin dimer | C32H38N6O10S2 | 2088960-43-2 | Details |
Atorvastatin Impurity | C33H33FN2O4 | 125995-03-1 | Details |
Atorvastatin Amlodipine Dimer | C53H58ClFN4O9 | 425408-16-8 | Details |
Sildenafil Impurity | C9H8Cl2O2 | 60531-34-2 | Details |
Bendamustine Desmethyl Impurity | C15H19Cl2N3O2 | 41515-13-3 | Details |
Paliperidone Impurity | C2H7NO3S | 4403-49-0 | Details |
Edaravone Impurity | C13H14N2O6S | 1357477-99-6 | Details |
Ozagrel Impurity | C23H20N2O4 | 883942-98-1 | Details |
Paroxetine Impurity | C12H14FN | 69675-10-1 | Details |
R-PraMipexole Dihydrochloride Monohydrate | C10H20ClN3OS | 908244-04-2 | Details |
Paroxetine Impurity | C12H16FNO | 125224-43-3 | Details |
Deferasirox Impurity | C14H9NO3 | 1218-69-5 | Details |
Lansoprazole Impurity | C8H11NO2 | 102625-96-7 | Details |
Nicorandil Impurity 1 Dinitrate | C24H27N8O9+ | 2365474-06-0 | Details |
Mupirocin EP Impurity C | C26H42O9 | 85248-93-7 | Details |
DMEP | C13H16O4 | 34006-76-3 | Details |
Ticagrelor Impurity | C27H42N6O8S | 2205903-74-6 | Details |
Mono-POC Tenofovir (Mixture of Diastereomers) | C14H22N5O7P | 211364-69-1 | Details |
Product Total: Product Page: | ||||
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 |